Statin use is associated with higher white matter hyperintensity volumes and lower grey matter volumes
2024

Statin Use and Brain Volume Changes

Sample size: 3285 publication 10 minutes Evidence: high

Author Information

Author(s): Gentreau Mélissa, Miguet Maud, Affatato Oreste, Rukh Gull, Schiöth Helgi Birgir

Primary Institution: University of Uppsala

Hypothesis

What is the association between statin use and brain volumes in middle-aged and older adults?

Conclusion

Statin use is associated with higher white matter hyperintensity volumes and lower grey matter volumes over a 9-year period.

Supporting Evidence

  • Statin users had a mean grey matter volume reduction of 1575 mm3.
  • Statin use was associated with a 20% mediation effect by total serum cholesterol concentration.
  • Statin users exhibited higher white matter hyperintensity volumes compared to non-users.

Takeaway

People who take statins may have smaller brain areas and more white matter damage over time.

Methodology

This cross-sectional study analyzed brain volumes using MRI in a large population-based sample, comparing statin users and non-users.

Potential Biases

Potential recall bias in self-reported health conditions.

Limitations

The study is cross-sectional and cannot establish causation; it also lacks detailed information on statin dosage and duration.

Participant Demographics

Participants were middle-aged and older adults from the UK Biobank, with a mean age of 60 years for statin users and 55 years for non-users.

Statistical Information

P-Value

<0.0001

Confidence Interval

−2358, −791 for grey matter volume

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1093/braincomms/fcae417

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication